UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2129-2135

2015

Link zum Volltext

Verfügbarkeit prüfen

Angiogenesis in cancer

Vascular health and risk management, 2006, Vol.2 (3), p.213-219

2006

Link zum Volltext

Verfügbarkeit prüfen

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

International journal of clinical oncology, 2015-10, Vol.20 (5), p.855-865

2015

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2798-2803

2007

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1727-1732

2010

Link zum Volltext

Verfügbarkeit prüfen

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

Cancer science, 2015-09, Vol.106 (9), p.1111-1117

2015

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

International journal of clinical oncology, 2017-04, Vol.22 (2), p.405-412

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.785-790

2016

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer

Gynecologic oncology, 2014-03, Vol.132 (3), p.703-708

2014

Link zum Volltext

Verfügbarkeit prüfen

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

Gynecologic oncology, 2012-05, Vol.125 (2), p.307-311

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan

Gynecologic oncology, 2012-11, Vol.127 (2), p.338-344

2012

Link zum Volltext

Verfügbarkeit prüfen

Overview on the 1st international workshop on gynecologic oncology

Journal of Gynecologic Oncology, 2010, 21(3), , pp.135-136

Kamura, Toshiharu

2010

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for advanced or recurrent cervical cancer

Taiwanese journal of obstetrics & gynecology, 2013-06, Vol.52 (2), p.161-164

2013

Link zum Volltext

Verfügbarkeit prüfen

Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats

The journal of obstetrics and gynaecology research, 2015-04, Vol.41 (4), p.540-550

2015

Link zum Volltext

Verfügbarkeit prüfen

RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer

PloS one, 2013-08, Vol.8 (8), p.e72820-e72820

2013

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study

International journal of clinical oncology, 2013-02, Vol.18 (1), p.126-131

2013

Link zum Volltext

Verfügbarkeit prüfen

A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer

Japanese journal of clinical oncology, 2010-05, Vol.40 (5), p.456-463

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas

Magnetic Resonance in Medical Sciences, 2015/11/01, Vol.14(4), pp.295-304

2015

Link zum Volltext

Verfügbarkeit prüfen

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma

Cancer letters, 2008-06, Vol.264 (1), p.36-43

2008

Link zum Volltext

Verfügbarkeit prüfen

Optimization of a novel nylon mesh container for human embryo ultrarapid vitrification

Fertility and sterility, 2010-05, Vol.93 (7), p.2405-2410

2010

Link zum Volltext

Verfügbarkeit prüfen

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Gynecologic oncology, 2009-04, Vol.113 (1), p.57-62

2009

Link zum Volltext

Verfügbarkeit prüfen

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device

Journal of Gynecologic Oncology, 2014, 25(3), , pp.229-235

2014

Link zum Volltext

Verfügbarkeit prüfen

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101)

Japanese journal of clinical oncology, 2015-01, Vol.45 (1), p.123-126

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Japanese journal of clinical oncology, 2010-01, Vol.40 (1), p.90-93

2010

Link zum Volltext

Verfügbarkeit prüfen

Diffusion-weighted MR imaging in gynecologic cancers

Journal of Gynecologic Oncology, 2011, 22(4), , pp.275-287

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(197)

Publikationsform

Artikel
(210)
Berichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Female
(145)
Humans
(143)
Science & Technology
(135)
Life Sciences & Biomedicine
(134)
Oncology
(109)
Adult
(80)
Middle Aged
(79)
Biological And Medical Sciences
(69)
Medical Sciences
(69)
Aged
(64)
Obstetrics & Gynecology
(63)
Gynecology. Andrology. Obstetrics
(52)
Tumors
(50)
Female Genital Diseases
(46)
Prognosis
(34)
Ovarian Neoplasms - Pathology
(32)
Cancer Research
(31)
Neoplasm Staging
(31)
Ovarian Neoplasms - Drug Therapy
(29)
Uterine Cervical Neoplasms - Pathology
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Angiogenesis in cancer

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan

Overview on the 1st international workshop on gynecologic oncology

Chemotherapy for advanced or recurrent cervical cancer

Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats

RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study

A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer

Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma

Optimization of a novel nylon mesh container for human embryo ultrarapid vitrification

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101)

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Diffusion-weighted MR imaging in gynecologic cancers

Suchergebnisse filtern